PANDEIA THERAPEUTICS LIMITED
Company number 11463856 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£7,310,040
Balance sheet as at 2024-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2018-07-13
- Employees
- 1 (2024 accounts)
- Registered office
- The Cambridge Partnership The Dorothy Hodgkin Bldg Babraham Research Campus, Babraham, Cambridge, England, CB22 3FH
- Postcode
- CB22 3FH
- Capital
- 5 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-06-26
- Next due by
- 2027-07-10
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 6 resigned
Jennifer RHODES
Director
THE CAMBRIDGE PARTNERSHIP LIMITED
Secretary · corporate
Group structure
Controlled by Medicxi Ventures I Lp (00002010) — since 2019-09-20
From persons-with-significant-control filings on the public register.
Contact details
- Website
- pandeiatherapeutics.com
Previous registered addresses 4
| Address | Changed on |
|---|---|
| C/O THE CAMBRIDGE PARTNERSHIP LIMITED THE DOROTHY HODGKIN BUILDING, BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3AT, UNITED KINGDOM | 2020-10-02 |
| C/O THE CAMBRIDGE PARTNERSHIP MONETA, BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3AT, ENGLAND | 2020-08-27 |
| BIOHUB ALDERLEY PARK, MACCLESFIELD, CHESHIRE, SK10 4TG, ENGLAND | 2019-08-05 |
| 29A RECTORY LANE, LYMM, WA13 0AJ, UNITED KINGDOM | 2018-07-27 |
Competitors Cambridge
This company ranks 224 among research and experimental development on biotechnology in Cambridge.
The class of 2018
36%
of the 439 companies in this sector incorporated in 2018 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.